Crawford gets nod from Bush on FDA Commissionership
This article was originally published in Clinica
Executive Summary
As expected, President Bush this week named acting FDA commissioner Lester Crawford to fill the long-vacant top spot at the embattled agency. The low-key announcement in the form of a terse press release came virtually on the eve of a high- profile three day FDA panel meeting on the health risks of Vioxx and other Cox-2 inhibitors.